Berger, M.; Daubin, D.; Charriot, J.; Klouche, K.; Le Moing, V.; Morquin, D.; Halimi, L.; Jaussent, A.; Taourel, P.; Hayot, M.;
et al. Mid-Term Sequelae of Surviving Patients Hospitalized in Intensive Care Unit for COVID-19 Infection: The REHCOVER Study. J. Clin. Med. 2023, 12, 1000.
https://doi.org/10.3390/jcm12031000
AMA Style
Berger M, Daubin D, Charriot J, Klouche K, Le Moing V, Morquin D, Halimi L, Jaussent A, Taourel P, Hayot M,
et al. Mid-Term Sequelae of Surviving Patients Hospitalized in Intensive Care Unit for COVID-19 Infection: The REHCOVER Study. Journal of Clinical Medicine. 2023; 12(3):1000.
https://doi.org/10.3390/jcm12031000
Chicago/Turabian Style
Berger, Marie, Delphine Daubin, Jeremy Charriot, Kada Klouche, Vincent Le Moing, David Morquin, Laurence Halimi, Audrey Jaussent, Patrice Taourel, Maurice Hayot,
and et al. 2023. "Mid-Term Sequelae of Surviving Patients Hospitalized in Intensive Care Unit for COVID-19 Infection: The REHCOVER Study" Journal of Clinical Medicine 12, no. 3: 1000.
https://doi.org/10.3390/jcm12031000
APA Style
Berger, M., Daubin, D., Charriot, J., Klouche, K., Le Moing, V., Morquin, D., Halimi, L., Jaussent, A., Taourel, P., Hayot, M., Cristol, J.-P., Nagot, N., Fesler, P., & Roubille, C.
(2023). Mid-Term Sequelae of Surviving Patients Hospitalized in Intensive Care Unit for COVID-19 Infection: The REHCOVER Study. Journal of Clinical Medicine, 12(3), 1000.
https://doi.org/10.3390/jcm12031000